Effective blood pressure reduction: results of the regional program “DOVERIE”
https://doi.org/10.15829/1560-4071-2018-12-57-63
Abstract
In clinical practice, quite often the practitioner faces difficulties in correcting arterial pressure in patients with arterial hypertension. Patients mostly for various reasons prefer to be treated with generic drugs, sometimes to the detriment of the effectiveness of treatment. The regional study conducted by us clearly showed the presence of additional possibilities of the original drug Prestans (Servier, France) in reducing blood pressure compared to equivalent dosages of generic fixed combinations.
About the Authors
N. V. Dobryninа
Ryazan State Medical University named after academician I. P. Pavlov
Russian Federation
Ryazan
Russian Federation
Ryazan
S. S. Yakushin
Ryazan State Medical University named after academician I. P. Pavlov
Russian Federation
Ryazan
Russian Federation
Ryazan
References
1. Research organizing committee of the ESSE-RF project. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Preventive medicine. 2013;6:25-34. (In Russ.)
2. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Russ J Cardiol. 2014;19(1):7-94. (In Russ.)
3. Loukianov MM, Boytsov SA, Yakushin SS, et al. Сoncomitant cardiovascular diseases and antihypertensive treatment in outpatient practice (by the RECVASA registry data) Rational pharmacotherapy in cardiology. 2016;12(1):4-15. (In Russ.)
4. Pereverzeva KG, Vorobyev AN, Nikulina NN, et al. Peculiarities of examination of patients with ischemic heart disease in outpatient practice according to gross observation. I. P. Pavlov Russian Medical Biological Herald. 2014;1:90-6. (In Russ.)
5. Yakushin SS, Filippov EV. The main directions of primary prevention of cardiovascular diseases. Science of young — Eruditio Juvenium. 2014;4:55-68. (In Russ.)
6. Filippov EV, Yakushin SS. Prevalence of arterial hypertension and peculiarities of management of patients with arterial hypertension and various risks of cardiovascular complications (according to the study of MERIDIAN-RO). Medical Council. 2013;9:65-9. (In Russ.)
7. Boytsov SA, Balanova YuA, Shalnova SA, et al. hypertension among persons 25-64 years of age: prevalence, awareness, treatment and control. According to the research ESSAY. Cardiovascular therapy and prevention. 2014;13(4):4-14. (In Russ.)
8. Filippov EV. The original efficacy of perindopril in patients with arterial hypertension: results of the “PRIZNANIE” regional program. Heart: journal for practitioners. 2015;14(5):308-15. (In Russ.)
9. Martsevich SYu, Zagrebelnyy AV, Lukinа YuV, et al. The Analysis of practice of application of combination therapy of antihypertensive drugs in two outpatient registers. Russian journal of cardiology. 2017;22(8):107-13. (In Russ.)
10. Belousov YB, Leonova MV, Belousov DYu, et al. Results of pharmacoepidemiological study of patients with arterial hypertension in Russia (PYTHAGORAS II). Qualitative clinical practice. 2004;1:17-27. (In Russ.)
11. Leonova MV, Belousov DY, Steinberg LL, analytical research group PYTHAGORAS. The first results of pharmacoepidemiological study of arterial hypertension PYTHAGORAS III. Quality clinical practice. 2010;1:54-60. (In Russ.)
12. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-25.
Review
For citations:
Dobryninа N.V., Yakushin S.S. Effective blood pressure reduction: results of the regional program “DOVERIE”. Russian Journal of Cardiology. 2018;(12):57-63. (In Russ.) https://doi.org/10.15829/1560-4071-2018-12-57-63
Views:
1034
Email this article 